Helus Pharma, Inc. (HELP)
10.71
-0.20
(-1.83%)
USD |
NASDAQ |
Oct 29, 16:00
10.60
-0.11
(-1.03%)
After-Hours: 20:00
Helus Pharma EPS Diluted (Quarterly) : -0.914 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.914 |
| March 31, 2026 | -0.9346 |
| December 31, 2025 | -1.004 |
| September 30, 2025 | -1.393 |
| June 30, 2025 | -1.099 |
| March 31, 2025 | -1.020 |
| December 31, 2024 | -0.3769 |
| September 30, 2024 | -2.096 |
| June 30, 2024 | -0.5532 |
| March 31, 2024 | -0.7912 |
| December 31, 2023 | -2.536 |
| September 30, 2023 | -1.436 |
| June 30, 2023 | -0.0524 |
| March 31, 2023 | -1.965 |
| December 31, 2022 | -0.0419 |
| September 30, 2022 | -0.0422 |
| Date | Value |
|---|---|
| June 30, 2022 | -2.209 |
| March 31, 2022 | -0.0822 |
| December 31, 2021 | -3.019 |
| September 30, 2021 | -3.203 |
| June 30, 2021 | -2.888 |
| March 31, 2021 | -0.0723 |
| December 31, 2020 | -3.021 |
| July 31, 2019 | -0.0418 |
| April 30, 2019 | -0.0864 |
| January 31, 2019 | -0.0217 |
| October 31, 2018 | -0.0575 |
| July 31, 2018 | -0.1314 |
| April 30, 2018 | -0.0188 |
| January 31, 2018 | -0.3003 |
| October 31, 2017 | -0.0109 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | -1.434 |
| NervGen Pharma Corp. | -0.0925 |
| Milestone Pharmaceuticals, Inc. | -0.2063 |
| Appili Therapeutics, Inc. | -0.0093 |
| Clearmind Medicine, Inc. | -4.588 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -47.82M |
| Total Expenses (Quarterly) | 47.82M |
| Enterprise Value | 509.88M |
| Earnings Yield | -39.64% |
| Normalized Earnings Yield | -38.19 |